Lisa Taylor-Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy. A recap of the top video interviews from Contemporary OB/GYN's ...
Chrisandra Shufelt, MD, on using a cardiovascular risk score to guide hormone therapy candidacy at menopause. Chrisandra L. Shufelt, MD, MS, FACP, MSCP, professor and chair of the Division of General ...
Nearly half of menopausal sleep disruption tracks with nighttime hot flashes, while the remainder appears independent, making nocturnal fragmentation a distinct clinical target rather than a secondary ...
Sleep disturbance is often the most bothersome symptom of the menopause transition, yet it frequently goes unreported unless clinicians ask directly about sleep quality and daytime fatigue. Welcome ...
The October 30 update from the FDA follows the February 12, 2026 labeling changes to 6 menopausal hormone therapy products in which the agency also removed safety-related boxed warnings. The FDA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results